Scott G. Stephen - 14 Apr 2026 Form 4 Insider Report for cbdMD, Inc. (YCBD)

Reporting relationship: Director
Issuer ticker: YCBD
Reported as of: 14 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Apr 2026, 20:15:02 UTC
Prior SEC filing: 20 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Scott Stephen

Key filing fact

Scott G. Stephen filed Form 4 for cbdMD, Inc. (YCBD) on 16 Apr 2026.

Key facts

This page summarizes Scott G. Stephen's Form 4 filing for cbdMD, Inc. (YCBD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Apr 2026, 20:15.

Change

Previous filing in this sequence was filed on 20 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001773957 Primary reporting owner

Stephen Scott G.

Relationship: Director
Address: 2101 WESTINGHOUSE BLVD. SUITE A, CHARLOTTE
Signature: /s/ Scott Stephen
Signature date: 16 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YCBD transaction

Common Stock

Award

Transaction value
Shares: +1,572
Change %: +55%
Price: $0.000000^*
Shares after: 4,412
Date: 14 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.